DGKV

We care
Ask our clients
After every detail
We care
The intelligent way
New vision of the legal profession
Ahead of time
Understanding the law
The clever solution

Search:

General Corporate

M&A, Privatisation, Joint ventures

Infrastructure & Transport

Real Estate & Construction

Environment

Intellectual Property

Taxation

Employment & Social Security

Litigation

Media, Entertainment & Sports

Workouts & Insolvency

Pharma Regulatory

Print this page

Practice Area

Pharma Regulatory

Clients | Representative transactions | Contact

Abbott Laboratories, Amgen (Europe) GmbH, Amgen Limited, Array BioPharma Inc., Aventis Pharma International S.A., B. Braun, Bank of America, Bayer AG, Bio Generix AG, BIOTRONIK GmbH & Co. KG, Boston Scientific Corporation, CSL Behring Beteiligungs- und Verwaltungs GmbH & Co KG, Deutsche Bank, EBRD, Fournier Pharma Inc., GE Medical Systems Information Technologies GmbH, Genesis Pharma S. A., Genzyme Corporation, Genzyme Europe BV, GlaxoSmithKline, GlaxoSmithKline EOOD, H. Lundbeck A/S, I.N.C. Agency B.V., ICN Pharmaceuticals, King Pharmaceuticals, LEK farmacevtska družba d.d., Les Laboratoires Servier, Merz Pharmaceuticals GmbH, Mundipharma, Novartis AG, Pfizer, Protein Design Labs, S.C. Johnson & Son, Inc., Sanofi Aventis, Schering Plough, Solvay, SSL Magyarorszag Kft, Standard Bank Plc, Texas Pacific Group, Tukanna Banka Osteocenter Bulgaria EAD, Vector Tobacco, Zentiva International a.s., ZymoGenetics, Inc.

Client: Deutsche Bank

Deutsche Bank in the process of privatisation of three of the largest pharmaceutical manufacturing facilities in Bulgaria - Antibiotic Razgrad, Pharmatsia Dupnitsa and Troyapharm Troyan. The work included due diligence, transaction advice well as on the subsequent restructuring and financing issues

Other areas: Banking & Finance, Employment & Social Security, M&A, Privatisation, Joint ventures, Workouts & Insolvency